Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -10.37% is 145% below its 5-year average of 23.30%, near the low end of its 5-year range (-10.37%–85.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.39% below its 12-month average of -6.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
-10.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-6.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-5.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
23.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-55.39%
CURRENT VS 3Y AVG
-107.49%
CURRENT VS 5Y AVG
-144.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-218.62%
vs the sector median at left
BioNTech SE
Market Cap
$24.67B
Return on Invested Capital (ROIC)
-10.37%
TTM Avg
-6.68%
3Y Avg
-5.00%
5Y Avg
23.30%
Market Cap
$23.84B
Return on Invested Capital (ROIC)
15.77%
TTM Avg
14.65%
3Y Avg
16.96%
5Y Avg
17.76%
Market Cap
$25.71B
Return on Invested Capital (ROIC)
22.95%
TTM Avg
10.25%
3Y Avg
9.28%
5Y Avg
7.08%
Market Cap
$25.90B
Return on Invested Capital (ROIC)
8.25%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$26.18B
Return on Invested Capital (ROIC)
38.57%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$26.36B
Return on Invested Capital (ROIC)
8.02%
TTM Avg
6.33%
3Y Avg
5.68%
5Y Avg
7.63%
Market Cap
$21.45B
Return on Invested Capital (ROIC)
17.69%
TTM Avg
15.79%
3Y Avg
14.57%
5Y Avg
13.09%
Market Cap
$21.03B
Return on Invested Capital (ROIC)
8.74%
TTM Avg
7.84%
3Y Avg
7.14%
5Y Avg
6.51%
Market Cap
$28.80B
Return on Invested Capital (ROIC)
4.05%
TTM Avg
6.03%
3Y Avg
5.27%
5Y Avg
5.27%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.67B | -10.37% | -6.68% | -5.00% | 23.30% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.84B | 15.77% | 14.65% | 16.96% | 17.76% |
| Incyte Corporation (INCY)vs › | $25.71B | 22.95% | 10.25% | 9.28% | 7.08% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.90B | 8.25% | 7.70% | 8.24% | 10.04% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.18B | 38.57% | 38.26% | 37.51% | 36.01% |
| Labcorp Holdings Inc. (LH)vs › | $26.36B | 8.02% | 6.33% | 5.68% | 7.63% |
| United Therapeutics Corporation (UTHR)vs › | $21.45B | 17.69% | 15.79% | 14.57% | 13.09% |
| STERIS plc (STE)vs › | $21.03B | 8.74% | 7.84% | 7.14% | 6.51% |
| Medline Inc. (MDLN)vs › | $28.80B | 4.05% | 6.03% | 5.27% | 5.27% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.54B | 6.94% | 7.96% | 8.07% | 9.18% |
ROIC
-10.4%
ROE
-9.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -10.37% |
| 2026-03-31 | -7.56% |
| 2025-12-31 | -6.40% |
| 2025-09-30 | -4.76% |
| 2025-06-30 | -4.29% |
| 2025-03-31 | -6.79% |
| 2024-12-31 | -6.82% |
| 2024-09-30 | -4.46% |
| 2024-06-30 | -4.35% |
| 2024-03-31 | -1.75% |
| 2023-12-31 | 2.56% |
| 2023-09-30 | 12.76% |
| 2023-06-30 | 19.82% |
| 2023-03-31 | 26.47% |
| 2022-12-31 | 45.01% |
| 2022-09-30 | 59.23% |
| 2022-06-30 | 71.48% |
| 2022-03-31 | 80.73% |
| 2021-12-31 | 85.66% |
| 2021-09-30 | 72.06% |
| 2021-06-30 | 70.98% |
| 2021-03-31 | 44.17% |
| 2020-12-31 | -3.65% |
| 2020-09-30 | -31.30% |
| 2020-06-30 | -29.68% |
| 2020-03-31 | -33.58% |
| 2019-12-31 | -27.38% |
| 2019-09-30 | -22.03% |
| 2019-06-30 | -19.72% |
| 2018-12-31 | -10.55% |
